Quantitative Gene Expression Analysis
Quantitative gene expression analysis is the set of molecular methods used to measure how much a gene is expressed in a tissue or cell population, by quantifying messenger RNA transcripts or their protein products. Within molecular pathology it provides the numerical evidence that links a sample's molecular activity to diagnosis, classification, and prognosis.
Definition
Quantitative gene expression analysis is the measurement of the abundance of gene products (RNA transcripts or proteins) in a biological sample, expressed on a relative or absolute scale, to characterise the molecular state of cells or tissues.
Scope
This area orients the reader across the principal quantitative platforms used in pathology and laboratory medicine: real-time and quantitative PCR, RNA sequencing and transcriptomics, immunohistochemistry and other protein-detection methods, the prognostic gene-expression signatures derived from these measurements, and the quality-assurance practices that make the numbers reliable. It frames these as measurement methodologies rather than as clinical instructions.
Sub-topics
Core questions
- How is the abundance of a transcript or protein measured and normalised?
- When is a relative measurement sufficient and when is absolute quantification needed?
- How are expression measurements translated into diagnostic or prognostic classification?
- What controls and standards make a quantitative result reproducible across laboratories?
Key concepts
- Transcript abundance and protein abundance
- Relative versus absolute quantification
- Normalisation and reference genes
- Gene expression signatures
- Analytical validity and reproducibility
- Pre-analytical, analytical, and post-analytical phases
Mechanisms
All quantitative expression methods convert a molecular quantity into a measurable signal that scales with the amount of target. Reverse-transcription quantitative PCR amplifies cDNA and reads the cycle at which fluorescence crosses a threshold, with relative quantification typically reported by the comparative 2-DDCT approach (Livak & Schmittgen, 2001). RNA sequencing counts reads mapped to transcripts, turning sequence depth into expression estimates (Wang et al., 2009). Immunohistochemistry detects protein with labelled antibodies and reports staining intensity and extent. Across platforms, raw signal must be normalised to reference standards so that biological differences can be separated from technical variation, a requirement formalised for qPCR by the MIQE guidelines (Bustin et al., 2009).
Clinical relevance
Quantitative expression measurements underpin molecular tumour classification, biomarker reporting, and multigene prognostic tests, and reading them critically is part of laboratory-medicine practice. This entry describes how such measurements are generated and interpreted as a field of method; it is not a source of diagnostic thresholds or treatment decisions, which belong to validated assays and clinical guidelines.
Evidence & guidelines
The methodological literature spans reporting standards such as the MIQE guidelines for qPCR (Bustin et al., 2009), foundational descriptions of RNA-seq as a quantitative platform (Wang et al., 2009; Mortazavi et al., 2008), and landmark demonstrations that expression profiles carry prognostic information (van 't Veer et al., 2002). Together these define both the techniques and the standards by which their results are judged.
History
Quantitative expression analysis grew from low-throughput Northern blots and early RT-PCR toward real-time PCR in the 1990s, microarray-based profiling around 2000, and high-throughput RNA sequencing from the late 2000s. The 2002 breast-cancer profiling study (van 't Veer et al.) showed expression patterns could predict outcome, and the 2009 MIQE guidelines marked a shift toward standardised, reproducible quantification.
Key figures
- Stephen Bustin
- Kenneth Livak
- Laura van 't Veer
Related topics
Seminal works
- bustin-2009
- wang-2009
- vantveer-2002
- livak-2001
Frequently asked questions
- What is the difference between relative and absolute quantification?
- Relative quantification compares a target's expression to a reference (for example, the comparative 2-DDCT method in qPCR), while absolute quantification reports a true copy number or concentration against a calibrated standard. Most expression studies use relative measures; absolute measures require additional calibration.
- Why is normalisation necessary in expression analysis?
- Raw signal reflects both biological expression and technical factors such as input amount, efficiency, and sequencing depth; normalisation to reference genes or standards removes the technical component so that measured differences reflect genuine biology.